Companies: 10,795·Total market cap: $144.5T
LB Pharmaceuticals Inc Common Stock

LB Pharmaceuticals Inc Common Stock

LBRXNASDAQHealthcare● Active
$28.74
+$0.21(+0.75%)
Market Cap$824275950
P/E Ratio
52W High$33.47
52W Low$13.36
Overview

LB Pharmaceuticals Inc Common Stock(LBRX)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

lbrx · 股价预测 · 1 位分析师(近3月)· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 1 位华尔街分析师

SellBuy

Buy

1 位分析师

共识

评级分布

Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
合计: 1 · 买入占比: 100.0%

12 个月目标价

High

$45.00

Consensus

$39.50

+37.2% upside

Low

$36.00

Median: $38.5 · Last Close: $28.79

LB Pharmaceuticals Inc Common Stock(LBRX)的分析师共识为 Buy,基于过去 3 个月内 1 位华尔街分析师的评级。LBRX 的 12 个月平均目标价为 $39.50,相对当前价 $28.79 代表 +37.2% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

Historical priceConsensus $40 (37.2%)

Consensus Target

$39.50

37.2% upside

High Target

$45

56.3%

Low Target

$36

25.1%

Current Price

$28.79

as of today

Based on analyst price targets, the LBRX stock price prediction for the next 12 months ranges from $36 to $45. The consensus LBRX price forecast of $39.50 implies 37.2% upside from the current price of $28.79.

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-09$28.321.61%

1-day model range: $28.18–$28.47. Peak: $28.47 (-1.61%).

长期股价预测

⚠️ 在满 252 个交易日历史(IPO/上市时间较短)前不展示长期预测;短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

BULLISH

Based on 14 technical indicators

57%22%21%
8Buy
3Neutral
3Sell
RSI (14)58.2Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · LBRX · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$28.24BUY
MA 10$28.08BUY
MA 20$28.86SELL
MA 50$28.85SELL
MA 100$26.16BUY
MA 200$0.00NEUTRAL
Current $LBRX · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$28.44BUY
EMA 10$28.38BUY
EMA 20$28.72BUY
EMA 50$28.28BUY
EMA 100$26.14BUY
EMA 200$0.00NEUTRAL
Current $LBRX · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
Stifel2026-03-27
Maintains
BuyBuy
Stifel2025-12-11
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on LB Pharmaceuticals Inc Common Stock (LBRX) stock. Of the recent 2 rating actions, 0 were upgrades and 0 were downgrades. 1 analysts currently cover LBRX.

分析师推荐趋势

Buy ratings11
Hold ratings00
Sell ratings00

LBRX analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$0M

Revenue Next Year

$0M

EPS This Year

$-3.52

EPS Next Year

$-4.39

↑ 24.5% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast LBRX EPS of $-3.52 for the current fiscal year, based on estimates from 5 analysts. The LBRX revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

LBRX 股价预测由两类独立数据源支撑:来自 1 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。LBRX 的共识目标价为 $39.50(+37.2% 上行空间),分析师共识为 Buy。

LBRX 的短期预测(明日)为 $28.32(-1.61%)。

LB Pharmaceuticals Inc Common Stock 在 NASDAQ 上市,代码 LBRX。LBRX 在 2027 年的整体展望偏积极,在覆盖分析师中约 100% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

LBRX 预测 · 8 个问题

根据 1 位华尔街分析师,LBRX 的 12 个月平均目标价为 $39.50,最高 $45.00、最低 $36.00。若有图表,中位目标价可在上方查看。相对当前价 $28.79,隐含约 +37.2% 的上行空间。

LBRX 目标价LBRX 分析师目标价LBRX 12个月目标价目标价 LBRX

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.